Julie E. Buring

University of North Carolina at Chapel Hill — United States

Medicine · Health Sciences

178h-index127.9kcitations1.3kworks4.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nutritional Studies and Diet(130), Liver Disease Diagnosis and Treatment(110), Genetic Associations and Epidemiology(92), Adipokines, Inflammation, and Metabolic Diseases(90), Pancreatic and Hepatic Oncology Research(69)

Publications1.2k total

Supplementary Figure S1 from Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival
2025Open Access
Supplementary Table S3 from Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival
2025Open Access
Supplementary Table S5 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Supplementary Table S5 from Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival
2025Open Access
Supplementary Table S1 from Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival
2025Open Access
Supplementary Table S2 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Supplementary Table S4 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Supplementary Table S1 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Supplementary Table S3 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Supplementary Figure S2 from Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival
2025Open Access
Supplementary Table S4 from Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival
2025Open Access
Supplementary Figure S2 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Supplementary Table S6 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Supplementary Table S9 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Supplementary Table S8 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Supplementary Table S7 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Supplementary Table S2 from Sex-Specific Associations between Adiponectin and Leptin Signaling and Pancreatic Cancer Survival
2025Open Access
Supplementary Figure S1 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Supplementary Table S10 from Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization
2025Open Access
Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis
JNCI Journal of the National Cancer Institute·2025Open Access
page 1 of 62Next →

Frequent Co-authors

Nancy R. Cook(20), Paul M. Ridker(18), JoAnn E. Manson(17), I‐Min Lee(12), J. Michael Gaziano(11), Nader Rifai(9), Charles H. Hennekens(9), David Gordon(6), Walter C. Willett(6), David J. Hunter(6), Samia Mora(5), Albert V. Smith(5), Rudolf Kaaks(4), Peter Kraft(4), Amy Hutchinson(4), Kevin B. Jacobs(4), Kai Yu(4), Anne Zeleniuch‐Jacquotte(4), Stephen J. Chanock(4), Patricia Hartge(4)